Andrew Paramore - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Andrew Paramore

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Nature Reviews. Drug Discovery|August 12, 2003

BortezomibAndrew Paramore, Simon Frantz

Clinicoeconomics and Outcomes Research : CEOR|September 26, 2022

Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score<sup>®</sup> Test in Node-Negative Early Breast CancerVladislav Berdunov, Steve Millen, Andrew Paramore, et al.

Journal of Medical Economics|April 13, 2022

Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score test in node-positive early breast cancerVladislav Berdunov, Steve Millen, Andrew Paramore, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Nature Reviews. Drug Discovery|August 12, 2003

BortezomibAndrew Paramore, Simon Frantz

Clinicoeconomics and Outcomes Research : CEOR|September 26, 2022

Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score<sup>®</sup> Test in Node-Negative Early Breast CancerVladislav Berdunov, Steve Millen, Andrew Paramore, et al.

Journal of Medical Economics|April 13, 2022

Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score test in node-positive early breast cancerVladislav Berdunov, Steve Millen, Andrew Paramore, et al.

Pageof 1